Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to $32.5 million.

  • Cross Country Healthcare's Shares Outstanding (Weighted Average) fell 356.97% to $32.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.5 million, marking a year-over-year decrease of 356.97%. This contributed to the annual value of $33.4 million for FY2024, which is 506.0% down from last year.
  • According to the latest figures from Q3 2025, Cross Country Healthcare's Shares Outstanding (Weighted Average) is $32.5 million, which was down 356.97% from $32.5 million recorded in Q2 2025.
  • In the past 5 years, Cross Country Healthcare's Shares Outstanding (Weighted Average) ranged from a high of $37.5 million in Q2 2022 and a low of $32.3 million during Q1 2025
  • For the 5-year period, Cross Country Healthcare's Shares Outstanding (Weighted Average) averaged around $35.3 million, with its median value being $35.6 million (2023).
  • Per our database at Business Quant, Cross Country Healthcare's Shares Outstanding (Weighted Average) skyrocketed by 234.1% in 2022 and then crashed by 565.23% in 2025.
  • Cross Country Healthcare's Shares Outstanding (Weighted Average) (Quarter) stood at $36.7 million in 2021, then rose by 0.88% to $37.0 million in 2022, then decreased by 5.01% to $35.2 million in 2023, then decreased by 5.06% to $33.4 million in 2024, then dropped by 2.56% to $32.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $32.5 million for Q3 2025, versus $32.5 million for Q2 2025 and $32.3 million for Q1 2025.